Alcon, Inc. (ALC)
Stock Price Chart
Key Info
| Market Cap | 29.83B |
| Revenue (ttm) | 7.51B |
| Net Income (ttm) | -656.00M |
| Shares Out | 491.70M |
| EPS (ttm) | -1.30 |
| PE Ratio | n/a |
| Forward PE | 29.67 |
| Dividend | n/a |
| Dividend Yield | n/a |
Stock Quote
| Trading Day | Oct 27, 2020 |
| Last Price | $60.66 |
| Previous Close | $61.25 |
| Change ($) | -0.59 |
| Change (%) | -0.96% |
| Day's Open | 61.17 |
| Day's Range | 60.66 - 61.19 |
| Day's Volume | 84,600 |
| 52-Week Range | 39.37 - 65.37 |
More Stats
| Market Cap | 29.83B |
| Enterprise Value | 32.82B |
| Earnings Date (est) | n/a |
| Ex-Dividend Date | n/a |
| Shares Outstanding | 491.70M |
| Float | 477.09M |
| EPS (basic) | -1.34 |
| EPS (diluted) | -1.30 |
| FCF / Share | 0.75 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Earnings Yield | n/a |
| FCF Yield | 1.23% |
| Payout Ratio | n/a |
| Shares Short | 4.92M |
| Short Ratio | 4.00 |
| Short % of Float | 1.03% |
| Beta | n/a |
| PE Ratio | n/a |
| Forward PE | 29.67 |
| P/FCF Ratio | 81.27 |
| PS Ratio | 3.97 |
| PB Ratio | 1.59 |
| Revenue | 7.51B |
| Operating Income | -242.00M |
| Net Income | -656.00M |
| Free Cash Flow | 367.00M |
| Net Cash | -3.00B |
| Net Cash / Share | -6.10 |
| Gross Margin | 53.48% |
| Operating Margin | -3.22% |
| Profit Margin | -8.70% |
| FCF Margin | 4.89% |
| ROA | -0.64% |
| ROE | -3.33% |
| ROIC | -3.00% |
Analyst Summary
Analyst Consensus: Overweight
Financial Performance
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|
| Revenue | 7,508 | 7,153 | 6,792 | 6,596 | 6,776 |
| Revenue Growth | 4.96% | 5.32% | 2.97% | -2.66% | - |
| Gross Profit | 3,662 | 3,192 | 3,204 | 3,111 | 3,247 |
| Operating Income | -242 | -295 | -124 | -40.00 | 364 |
| Net Income | -656 | -227 | 256 | -170 | 308 |
| Shares Outstanding | 488 | 488 | 488 | - | - |
| Earnings Per Share | -1.34 | -0.46 | 0.52 | - | - |
| Operating Cash Flow | 920 | 1,140 | 1,218 | 1,245 | 1,370 |
| Capital Expenditures | -553 | -524 | -414 | -444 | -440 |
| Free Cash Flow | 367 | 616 | 804 | 801 | 930 |
| Cash & Equivalents | 822 | 227 | 172 | 162 | 285 |
| Total Debt | 3,820 | 203 | 195 | 275 | 302 |
| Net Cash / Debt | -2,998 | 24.00 | -23.00 | -113 | -17.00 |
| Assets | 27,655 | 27,062 | 27,388 | 27,740 | 28,202 |
| Liabilities | 8,352 | 4,423 | 4,359 | 4,728 | 4,565 |
| Book Value | 19,303 | 22,639 | 23,029 | 23,012 | 23,637 |
Company Profile
Company Details
| Full Name | Alcon, Inc. |
| Country | Switzerland |
| Employees | 20,000 |
| CEO | David J. Endicott |
Stock Information
| Ticker Symbol | ALC |
| Stock Exchange | New York Stock Exchange |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Unique Identifier | NYSE: ALC |
Description
Alcon, an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients. It operates through two segments, Surgical and Vision Care. The Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures, such as cataracts, vitreoretinal, refractive laser, and glaucoma surgery. Its cataract products include centurion vision system, LenSx femtosecond laser, LuxOR ophthalmic microscope, verion imaged guided system, and ORA System for intra-operative measurements and guidance; vitreoretinal products comprising constellation vision system, grieshaber DSP and MIVS instrumentation, ultravit high speed vitrectomy probes, purepoint laser, and NGENUITY 3D visualization system; refractive surgery products, including WaveLight lasers and diagnostics used for LASIK; and glaucoma product, such as EX-PRESS glaucoma filtration device, as well as AcrySof IQ IOLs products include monofocal IOLs and advanced technology IOLs under PanOptix and ReSTOR brands for the correction of presbyopia and astigmatism at the time of cataract surgery. The Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, including devices and over-the-counter products for dry eye, over-the-counter products for contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers under the TOTAL, PRECISION, Dailies, Air Optix, Systane, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux brands. The company was formerly known as Alcon Universal S.A. and changed the name to Alcon, Inc. in December 2001. Alcon, Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.